Publications
Found 9 results
Filters: Author is Toya Nath Baral [Clear All Filters]
"Camelid immunoglobulins and nanobody technology.",
Vet Immunol Immunopathol, vol. 128, issue 1-3, pp. 178-83, 2009 Mar 15.
"Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.",
J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
"Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response.",
J Infect Dis, vol. 195, issue 10, pp. 1513-20, 2007 May 15.
"A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology.",
J Immunol, vol. 179, issue 6, pp. 4003-14, 2007 Sep 15.
"Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing.",
J Infect Dis, vol. 196, issue 6, pp. 954-62, 2007 Sep 15.
"[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].",
Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.",
Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
"Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections.",
J Infect Dis, vol. 193, issue 11, pp. 1575-83, 2006 Jun 1.
"VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology.",
Microbes Infect, vol. 4, issue 9, pp. 999-1006, 2002 Jul.